We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
Aurora Cannabis Inc. (ACB.TO)
| Previous Close | 7.44 |
| Open | 7.52 |
| Bid | 7.46 x 0 |
| Ask | 7.46 x 0 |
| Day's Range | 7.40 - 7.66 |
| 52 Week Range | 3.84 - 12.85 |
| Volume | |
| Avg. Volume | 753,130 |
| Market Cap | 408.316M |
| Beta (5Y Monthly) | 2.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.63 |
| Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.50 |
ZacksACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project
Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas.
- Baystreet
Stocks in play: Aurora Cannabis Inc.
Announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia ...
CNW GroupAurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –—the Canadian based leading global medical cannabis company, today announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia (Genome BC), a not-for-profit organization supporting world-class genomics research and innovation in British Columbia. The project, Genomics-enabled Aroma Breeding in Cannabis, will directly support Aurora's genetics work the project, is led by Drs. Jose Celedon, Principal Scie
The Motley FoolCan Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?
Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets. The post Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4? appeared first on The Motley Fool Canada.
CNW GroupAurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director. Both appointments follow unanimous votes by Aurora's Board and are effective immediately.
PR NewswireAurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pioneering ground-breaking research in auto-flowering technology. Auto-flowering is a genetic characteristic that automatically transitions the plant from the vegetative stage to the flowering stage rather than relying on changes in light cycles. This innovative work provides foundational insight on flowering mechanism in cannabis, which will support future breeding strategies, and can b
CNW GroupAurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge
Aurora Cannabis Inc. ("Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canadian-based global medical cannabis company, and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, are pleased to announce the launch of the newly developed Luo CBD lozenge.
CNW GroupAurora Cannabis Announces Results of 2024 Annual General and Special Meeting
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of
Simply Wall St.Aurora Cannabis First Quarter 2025 Earnings: Beats Expectations
Aurora Cannabis ( TSE:ACB ) First Quarter 2025 Results Key Financial Results Revenue: CA$83.4m (up 11% from 1Q 2024...
ZacksAurora Cannabis Inc. (ACB) Reports Q1 Loss, Tops Revenue Estimates
Aurora Cannabis (ACB) delivered earnings and revenue surprises of 68.57% and 20.16%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| WEED.TO Canopy Growth Corporation | |||
| CRON.TO Cronos Group Inc. | |||
| AC.TO Air Canada | |||
| BB.TO BlackBerry Limited | |||
| SHOP.TO Shopify Inc. |
Similar to ACB.TO
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| WEED.TO Canopy Growth Corporation | |||
| TLRY.TO Tilray Brands, Inc. | |||
| CRON.TO Cronos Group Inc. | |||
| OGI.TO Organigram Holdings Inc. | |||
| CGC Canopy Growth Corporation |
Analyst Price Targets (4)
Company Profile
90B Street SW
Suite 2207
Edmonton, AB T6X 1V8
Canada
855-279-4652
https://www.auroramj.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 1,073
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
